五羟色胺转运体启动子区CpG岛甲基化与精神分裂症的相关性研究
被引量:1
摘要
本文综述了DNA甲基化及5羟色胺转运体与精神分裂症的研究进展。通过分析三者之间的相关性,指出了精神分裂症发病原因的可能研究方向。
出处
《国际精神病学杂志》
2010年第1期16-19,共4页
Journal Of International Psychiatry
参考文献15
-
1王继才,陈晓岗.难治性精神分裂症[J].国际精神病学杂志,2009,36(1):12-16. 被引量:26
-
2Kundakovic M, Chen Y, Costa E, et al. DNA methyhransferase inhibitors coordinately induce expression of the human reelin and ghtamic acid decarboxylase 67 genes. Mol Pharmacol. 2007; 71 (3): 644-653.
-
3Tsujita T. Possible involvement of DNA methylation in pathogenesis of mental disorders - special reference to the twin study. Seishin Shinkeigaku Zasshi, 2004 ; 106 ( 1 ) : 36-37.
-
4Petronis A, Gottesman Ⅱ, Kan P, et al. Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance? Schizophr Bull. 2003 ; 29 ( 1 ) : 169-178.
-
5Iwamoto K, Bundo M, Yamada K, et al. A family-based and case-control association study of SOX10 in schizophrenia. Med Genet B Neuropsychiatr Genet. 2006; 141B (5) : 477-481.
-
6Lesch KP, Mossner R. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurode-generative disorders? Biol Psychiatry, 1998 ; 44 : 179-192.
-
7Bradley S, Dodelzon K, Sandhu H, et al. The relationship of serotonin transporter gene polymorphisms and haplotypes to mrna transcription. Am J Med Genet. 2005; 136: 58-61.
-
8Malhotra AK, Goldman D, Mazzanti C, et al. A functional transporter (5-HTF) Polymorphism is associated with psycho-sis in neuroleptic-free schizophrenics. Mol Psych. 1998; 3 : 328-332.
-
9Kaiser R, Tremblay PB, Schmider J, et al. Serotonin transporter polymorphisms : No association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Mol Psych. 2001 ; 6 :179-185.
-
10Govitrapong P, Mukda S, Turakitwanakan W, et al. Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment. Neurochemistry international, 2002; 41 (4): 209-216.
二级参考文献16
-
1Kane J. Treatment -resistant schizophrenic patient. J Clin Psychiatry, 1996; 57 (suppl 9) : 35 -40
-
2Lindenmayer J. Treatment refractory schizophrenia. Psychiatr Q. 2000; 71:373-384
-
3Saito M, Yasui Frukori N, Kaneko S, et al. Clinical pharmacogenetics in the treatment of schizophrenia. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 ; 25 : 129 - 135
-
4Zhang XY, Zhou DF, Cao LY, et al. Cortisol and cytokines in chronic and treatment -resistant patients with schizophrenia: association with psychopathology and response to antipsychotics. Neuropsychophamacology, 2005 ; 30 ( 8 ) : 1532 - 1538
-
5Staal WG, Hulshoff PHE, Schnack HG, et al. Structural brain abnormalities in chronic schizophrenia at the extremes of the outcome spectrum. Am J Psychiatry, 2001 ; 158 (7) : 1140 - 1142
-
6Kalla OA, honen J, Wahlstrom J, et al. Duration of untreated psychosis and its correlates in first - episode psychosis in Finland and Spain. Acta Psychiatr Scand. 2002; 106:358 - 364
-
7Geddes J, Freemantle N, Harrison P, et al. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta - regression analysis. BMJ. 2000; 321 (72) : 1371 - 1376
-
8Carpenter WT, Buchanan RW. Lessons to take home from CATIE. Psychiatr Serv. 2008 ; 59 (5) : 523 - 525
-
9McEvoy JP, Lieberman JA, Stroup TS, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry, 2006; 163 (4): 600-610
-
10Meltzer HY, Bobo WV, Roy A, et al. A randomized, double - blind comparison of clozapine and high - dose olanzapine in treatment -resistant patients with schizophrenia. J Clin Psychiatry, 2008 ; 69 (2) : 274 - 285
共引文献25
-
1谢拥军,王英兰,祁翠莲.丙戌酸镁对难治性精神分裂症的辅助作用[J].中国民康医学,2010,22(5):553-553.
-
2彭汝春,蔡金花,黄广文.奎硫平联合丙戊酸镁缓释片治疗难治性精神分裂症对照研究[J].临床心身疾病杂志,2010,16(2):118-119. 被引量:5
-
3谢拥军,王英兰,祁翠莲.丙戌酸镁对难治性精神分裂症的辅助治疗作用[J].中国民康医学,2010,22(8):972-972. 被引量:1
-
4曾宪茂,廖英.氯氮平合并改良电抽搐治疗难治性精神分裂症的对照研究[J].上海精神医学,2010,22(2):95-96. 被引量:8
-
5丁兆生,李佟.阿立哌唑合并氯氮平治疗难治性精神分裂症的对照研究[J].中国民康医学,2010,22(14):1780-1781. 被引量:9
-
6吴金丽,严明.齐拉西酮与利培酮治疗难治性精神分裂症对照研究[J].临床心身疾病杂志,2011,17(2):103-105. 被引量:7
-
7张春长,王学义,姚少敏.抗抑郁药在精神分裂症治疗中的应用状况[J].中国药物依赖性杂志,2011,20(2):84-86. 被引量:11
-
8胡小玲,欧阳东先,李晓红.精神疾病患者用药依从性现状与分析[J].医药导报,2011,30(5):685-688. 被引量:3
-
9丁宁,侯成业,张键.氯氮平和利培酮治疗难治性精神分裂症的对照分析[J].中国民康医学,2011,23(20):2484-2484. 被引量:4
-
10汪志良.氯氮平联合其他精神药物及电休克治疗难治性精神分裂症[J].临床精神医学杂志,2012,22(3):209-210. 被引量:7
同被引文献21
-
1无.关于印发健康中国行动——儿童青少年心理健康行动方案(2019—2022年)的通知[J].中华人民共和国国家卫生健康委员会公报,2019(12):18-21. 被引量:9
-
2李春波,邹政,方芳,汪栋祥,吴文源.五羟色胺转运体启动子区多态性与焦虑症的关联研究[J].中国行为医学科学,2006,15(1):34-35. 被引量:12
-
3赵连生,王英成,于跃,李涛,马小红.五羟色胺转运体基因多态性与青少年创伤后应激障碍的相关性研究[J].四川大学学报(医学版),2012,43(4):558-561. 被引量:4
-
4蒋华玉,王永刚.5-HTTLPR基因多态性与脑卒中后抑郁关系的meta分析[J].郑州大学学报(医学版),2014,49(6):778-783. 被引量:5
-
5陈仁智,朱敏,王婷,姬郁林.哮喘伴抑郁患者CD4^+T淋巴细胞五羟色胺受体及转运体基因的表达[J].四川大学学报(医学版),2016,47(2):222-226. 被引量:4
-
6杨冬冬,樊焱怀,许佳蕾,孙美珍.五羟色胺1A受体在癫痫合并抑郁中的研究进展[J].中华脑科疾病与康复杂志(电子版),2015,5(6):66-69. 被引量:1
-
7吕薇,白洁.抑郁症中免疫系统与五羟色胺系统的相互作用[J].中国老年学杂志,2016,36(7):1757-1759. 被引量:18
-
8周雪,丁春丽,王保捷,丁梅,庞灏.HTR1A基因与相应精神疾病的关联及法医学意义[J].中国法医学杂志,2017,32(6):596-598. 被引量:4
-
9薛竟雄,奚耕思,纪艳青,宋巧娟,张娟娟.强迫症的生物学机制和治疗综述[J].现代生物医学进展,2018,18(7):1387-1391. 被引量:7
-
10刘微,冉柳毅,靳佳佳,王苏亚,吴同,艾明,陈建梅,况利.五羟色胺受体基因和五羟色胺转运体基因交互作用与青年人自杀未遂行为的关系[J].第三军医大学学报,2018,40(12):1115-1119. 被引量:1
-
1董燕,程宇琪,徐健,许秀峰,白燕.5羟色胺转运体启动子区CpG岛甲基化与精神分裂症的相关研究[J].中国神经精神疾病杂志,2010,36(10):631-634. 被引量:3
-
2靳自斌,赵后锋,朱相华,耿德勤,乔娟.五羟色胺转运体启动子区基因多态性、应激事件与抑郁症的相关性[J].精神医学杂志,2014,27(6):434-436. 被引量:6
-
3周云飞,张亚林,胡纪泽,刘铁榜,刘妹,吴怀安,闫小华,余常红,赵幸福.五羟色胺转运体多态性与强迫症患者临床症状及认知功能的关系[J].中国行为医学科学,2007,16(9):804-806. 被引量:6
-
4刘恩益,刘玉平,文启琴,苗国栋,曾俏梅.五羟色胺转运体启动子区基因多态性与强迫症状和认知功能的关联研究[J].中华临床医师杂志(电子版),2013,7(7):84-86.
-
5刘丹,宋景贵.5-HTTLPR基因型与卒中后抑郁的相关性分析[J].中国实用神经疾病杂志,2014,17(16):25-27. 被引量:3
-
6董燕.重性抑郁(MDD)患者体内叶酸浓度与MB-COMT基因CpG岛甲基化状态的相关研究[J].国际精神病学杂志,2014,41(1):25-28.
-
7张海生,谢健,张顺泉,余道军,陈岳明.多巴胺受体D2型基因启动子区CpG岛甲基化状态与Ⅰ型和Ⅱ型精神分裂症的关联[J].中国神经精神疾病杂志,2012,38(7):439-442. 被引量:3
-
8徐宝艳,王宇明,邓国宏,罗元辉,杜泽丽,兰林,黄燕萍.乙型肝炎病毒感染后表型不一致的单卵孪生子基因组CpG岛甲基化谱差异分析[J].中华医学杂志,2005,85(33):2317-2321. 被引量:2
-
9王雪,祝三平,李静,黄明生.甲基苯丙胺的神经毒性及5-羟色胺转运体信使RNA的表达[J].中国临床康复,2006,10(10):118-120. 被引量:5
-
10余正和,王晟东,宋明芬.广泛性焦虑与5-HTTLPR多态性关联的Meta分析[J].中华全科医学,2015,13(12):1998-2000.